Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism FasL inhibitors(Soluble Fas ligand inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Atrophy | Preclinical | US | - | |
Atrophy | Preclinical | US | Visus Therapeutics, Inc.Startup | - |
Dystrophy, Macular | Preclinical | US | Visus Therapeutics, Inc.Startup | - |
Dystrophy, Macular | Preclinical | US | - |